Form 4: iRhythm Technologies Director Receives Equity Grant of 1,358 Restricted Stock Units

iRhythm Technologies, Inc. Director Abhijit Y Talwalkar was granted 1,358 restricted stock units (RSUs) on May 28, 2025, as part of his compensation, increasing his total beneficial ownership to 20,299 shares.

Summary

• Abhijit Y Talwalkar, a Director at iRhythm Technologies, Inc. (IRTC), acquired 1,358 restricted stock units (RSUs) on May 28, 2025.
• These RSUs were granted at a price of $0, indicating they are a form of equity compensation.
• Each RSU represents a contingent right to receive one share of IRTC Common Stock.
• The vesting of these RSUs will occur on the earlier of one year after the grant date or the date of the company's next annual meeting.
• Following this transaction, Mr. Talwalkar's beneficial ownership of iRhythm Technologies Common Stock stands at 20,299 shares.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a standard compensation practice and aligns management's interests with shareholders, indicating a neutral to slightly positive sentiment.

Positives

• The grant of restricted stock units to a director aligns their interests with those of long-term shareholders, incentivizing performance and value creation.

Future Outlook

The document indicates that the granted restricted stock units will vest on the earlier of one year after the grant date or the date of the company's next annual meeting, providing a future milestone for the equity compensation.

Industry Context

This filing represents a routine equity compensation event for a director, which is a common practice across publicly traded companies, including those in the healthcare technology sector, to attract and retain talent and align leadership incentives with shareholder value.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a common and standard practice for compensating board members in publicly traded companies, aligning their interests with long-term shareholder value.
• This compensation structure is consistent with practices observed across the healthcare technology sector for director remuneration.

Related Party Transactions

• The grant of restricted stock units to Director Abhijit Y Talwalkar constitutes a related party transaction, common for director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• Vesting of the 1,358 restricted stock units will occur on the earlier of one year after the grant date or the date of the company's next annual meeting.

Key Dates

Recommendation

Keywords

iRhythm Technologies, IRTC, Form 4, SEC filing, restricted stock units, RSU, equity grant, director compensation, insider transaction, Abhijit Y Talwalkar